Profem Overview

  • Founded
  • 2012
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Latest Deal Amount
  • $35.6K
Latest Deal Amount
  • Investors
  • 1

Profem General Information


Developer of medicines for gynecological diseases. The company develops new medicines for gynaecological diseases addressing a hitherto unmet medical need and recurrent vulvovaginal candidiasis.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Riglergasse 4/I
  • Vienna
  • Austria
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Profem Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator $35.6K Completed Startup
To view Profem’s complete valuation and funding history, request access »

Profem Executive Team (1)

Name Title Board Seat Contact Info
Marion Noe-Letschnig Founder & Chief Executive Officer
To view Profem’s complete executive team members history, request access »

Profem Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
INiTS Universitäres Gründerservice Accelerator/Incubator Minority 000 0000 000000 0
To view Profem’s complete investors history, request access »